Michael S. Magee
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Immunology 13
- Immunotherapy and Immune Responses 10
- Immune Cell Function and Interaction 6
- T-cell and B-cell Immunology 4
- Oncology 10
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Adam Eugene Snook (16 shared papers)Scott Arthur Waldman (15 shared papers)Glen P. Marszalowicz (7 shared papers)Trevor R. Baybutt (3 shared papers)Jieru Egeria Lin (4 shared papers)Michael Anthony Valentino (3 shared papers)Tara S. Abraham (2 shared papers)Stephanie Schulz (2 shared papers)
- Journals
- Journal of Clinical Investigation (2 papers)PLoS ONE (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Movement Disorders (1 paper)Biomarkers in Medicine (1 paper)
- Partner nations
- United StatesGermanyFinland
In The Last Decade
Michael S. Magee
19 papers receiving 739 citations
Peers
Comparison fields: 5 of 77
- Oncology 367
- Immunology 238
- Biotechnology 63
- Gastroenterology 27
- Aging 8
Countries citing papers authored by Michael S. Magee
This map shows the geographic impact of Michael S. Magee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Magee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Magee more than expected).
Fields of papers citing papers by Michael S. Magee
This network shows the impact of papers produced by Michael S. Magee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Magee. The network helps show where Michael S. Magee may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael S. Magee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 127 | |
| 2 | 2018 | 121 | |
| 3 | 2012 | 74 | |
| 4 | 2016 | 70 | |
| 5 | Colorectal cancer immunotherapy. | 2013 | 54 |
| 6 | Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancer. | 2014 | 39 |
| 7 | 2014 | 38 | |
| 8 | 2021 | 38 | |
| 9 | 2012 | 37 | |
| 10 | 2010 | 30 | |
| 11 | 2017 | 27 | |
| 12 | 2014 | 26 | |
| 13 | 2014 | 25 | |
| 14 | 2011 | 18 | |
| 15 | 2011 | 12 | |
| 16 | 2013 | 8 | |
| 17 | 2014 | 3 | |
| 18 | 2010 | 1 | |
| 19 | 2014 | 1 | |
| 20 | Measurement of speech as a biomarker of neurodegenerative disease using acoustic profiles and machine learning | 2020 | 0 |
About Michael S. Magee
Michael S. Magee is a scholar working on Immunology, Oncology, Biotechnology, Endocrinology and Endocrine and Autonomic Systems, having authored 20 papers that have together received 749 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer Research and Treatments (2 papers), Cancer Genomics and Diagnostics (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Oncology (367 citations), Immunology (238 citations), Biotechnology (63 citations), Gastroenterology (27 citations) and Aging (8 citations). Michael S. Magee has collaborated with scholars based in United States, Germany and Finland. Frequent co-authors include Adam Eugene Snook, Scott Arthur Waldman, Glen P. Marszalowicz, Trevor R. Baybutt, Jieru Egeria Lin, Michael Anthony Valentino, Tara S. Abraham, Stephanie Schulz, Terry Hyslop and Bo Xiang. Their work appears in journals such as Journal of Clinical Investigation, PLoS ONE, Journal for ImmunoTherapy of Cancer, Movement Disorders and Biomarkers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.